Women's Health Archive

The FDA added a boxed warning in December 2024 to fezolinetant (Veozah), a nonhormonal drug that reduces hot flashes and night sweats in menopausal women. The drug may cause rare but serious liver injury.

An estimated six in 10 women will at some point experience symptoms from pelvic floor weakness. Risk factors include pregnancy (especially with vaginal delivery), chronic constipation, family history, smoking, aging, menopause, obesity, chronic coughing, and occupations involving heavy lifting. Women with pelvic floor weakness may experience signs such as leaking urine, having trouble using a tampon, being unable to fully empty their bladder or rectum, and feeling a bulge in their vagina.

Although a clinical trial showed daily aspirin use didn't help women with breast cancer avoid recurrence or improve survival, other evidence-backed measures might. Exercise, weight control, and a healthy diet are linked with lower recurrence and longer survival, but alcohol use, smoking, and supplement use are not. While it's not always clear how lifestyle approaches help lower the odds of recurrence or death from breast cancer, healthy measures can improve women's ability to keep other conditions at bay or manage them more effectively.